Greene Barry E has filed 12 insider transactions across 2 companies since May 2023.
Most recent transaction: a transaction of 46940 shares of Sage Therapeutics, Inc. ($SAGE) on July 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | U | Common Stock | 46940 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.07% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | D | Stock Option (Right to Buy) | 174000 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.28% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | D | Common Stock | 53229 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.08% |
| May 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Greene Barry E | Not found | A | Nonstatutory Stock Option (right to buy) | 4600 | $0.00 | 4,600.0000 | 126,240,054 | 9999.99% | 0.00% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | A | Common Stock | 19964 | $0.00 | 105,031.0000 | 61,480,947 | 23.47% | 0.03% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | F | Common Stock | 4862 | $6.91 | 100,169.0000 | 61,480,947 | 4.63% | 0.01% |
| Jan. 16, 2025 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | A | Stock Option (Right to Buy) | 174000 | $0.00 | 174,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 5, 2024 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | A | Common Stock | 50400 | $0.00 | 97,340.0000 | 0 | 107.37% | 0.00% |
| Aug. 5, 2024 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | F | Common Stock | 12273 | $8.96 | 85,067.0000 | 0 | 12.61% | 0.00% |
| May 29, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Greene Barry E | Not found | A | Nonstatutory Stock Option (right to buy) | 69000 | $0.00 | 69,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2024 | Sage Therapeutics, Inc. | $SAGE | Greene Barry E | President and CEO | A | Stock Option (Right to Buy) | 168000 | $0.00 | 168,000.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Greene Barry E | Director | A | Nonstatutory Stock Option (right to buy) | 34000 | $0.00 | 34,000.0000 | 0 | 9999.99% | 0.00% |